Drug companies are racing to create vaccines to stifle a deadly swine virus that has roiled the U.S. meat industry and pushed pork prices to record highs.. Two companies—tiny Harrisvaccines Inc. and larger animal-health firm Zoetis Inc.—received conditional regulatory approval this summer to market vaccines for porcine epidemic diarrhea virus, which has spread to 31 states and killed millions of young pigs since it was first identified in the U.S. in April 2013. At least two other drug makers—Merck & Co. and Germany's Boehringer...
  